Global Information
회사소개 | 문의 | 비교리스트

세계의 혈장 분획 시장 예측(-2029년) : 제품별(면역글로불린(정맥내, 피하), 응고인자, 알부민), 용도별(면역학, 혈액학, 신경학), 최종사용자별(병원, 임상 검사실, 교육기관)

Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) - Forecast to 2029

리서치사 Meticulous Market Research Pvt. Ltd.
발행일 2022년 09월 상품코드 1124485
페이지 정보 영문 234 Pages 배송안내
가격
US $ 4,175 ₩ 6,040,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 1회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,875 ₩ 8,500,000 PDF (Multi User License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 5회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,875 ₩ 11,394,000 PDF (Global Site License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 혈장 분획 시장 예측(-2029년) : 제품별(면역글로불린(정맥내, 피하), 응고인자, 알부민), 용도별(면역학, 혈액학, 신경학), 최종사용자별(병원, 임상 검사실, 교육기관) Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) - Forecast to 2029
발행일 : 2022년 09월 페이지 정보 : 영문 234 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 혈장 분획 시장은 2022-2029년간 7.1%의 CAGR로 성장하여 2029년에는 468억 8,000만 달러에 달할 것으로 예측됩니다.

혈장 분획 시장의 주요 성장 촉진요인으로 모든 연령층의 만성질환 유병률 증가, 다양한 치료 분야의 면역글로불린 사용 증가, 혈장 채취 센터 확대 등을 들 수 있습니다. 또한 혈액질환이나 호흡기질환 유병률 증가가 시장 성장 기회를 조성하고 있습니다. 그러나 신흥 국가의 정부 규제 등의 요인이 이 시장 성장을 어느 정도 저해하고 있습니다.

제품별로 보면 2022년에는 면역글로불린 부문이 최대의 점유율을 차지할 것으로 예상됩니다.

용도별로 보면 2022년에는 신경학 분야가 시장을 독점할 것으로 예상됩니다.

최종사용자별로는 2022년에 병원·진료소 부문이 혈장 분획 시장을 독점할 것으로 추정됩니다.

2022년 세계의 혈장 분획 시장에서는 북미가 최대의 점유율을 차지하고, 유럽, 아시아태평양, 중남미, 중동 및 아프리카가 뒤를 이을 것으로 추정됩니다.

세계의 혈장 분획(Plasma Fractionation) 시장에 대해 분석했으며, 시장의 기본 구조와 주요 성장 촉진·억제요인, 전체적인 시장 동향 전망(2022-2029년), 제품별·용도별·최종사용자별·지역별 상세 동향, 최근 시장 경쟁·자본 거래 동향, 주요 기업 개요 등을 조사했습니다.

목차

제1장 서론

제2장 분석 방법

제3장 주요 요약

제4장 시장 인사이트

  • 서론
  • 시장 성장 촉진요인
    • 모든 연령층에서 증가하는 만성질환 유병률
    • 다양한 치료 분야에서의 면역글로불린 사용 증가
    • 혈장 채취 센터 확대
  • 시장 성장 억제요인
    • 플라즈마 제품 고가격
    • 재조합 대체품 사용 증가
  • 시장 기회
    • 혈액·호흡기질환 유병률 증가
  • 과제
    • 신흥국에서의 엄격한 규제
  • 혈장 분획 시장에 대한 COVID-19의 영향

제5장 혈장 분획 시장 : 제품별

  • 서론
  • 면역글로불린
    • 정맥내 면역글로불린(IVIg)
    • 피하 면역글로불린(SCIg)
    • 근육내 면역글로불린(IMIg)
  • 알부민
  • 프로테아제 억제제
  • 응고인자
  • 기타 제품

제6장 혈장 분획 시장 : 용도별

  • 서론
  • 신경학
  • 면역학
  • 혈액학
  • 구급 구명 치료
  • 혈액 종양학
  • 류머티즘·정형외과
  • 기타 용도

제7장 혈장 분획 시장 : 최종사용자별

  • 서론
  • 병원·진료소
  • 임상 검사실
  • 교육·연구기관

제8장 혈장 분획 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타 유럽 국가
  • 아시아태평양
    • 중국
    • 일본
    • 호주
    • 인도
    • 인도네시아
    • 베트남
    • 태국
    • 말레이시아
    • 기타 아시아태평양 국가
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 콜롬비아
    • 페루
    • 기타 라틴아메리카 국가
  • 중동 및 아프리카
    • 남아프리카공화국
    • 기타 중동 및 아프리카 국가

제9장 경쟁 상황

  • 서론
  • 주요 성장 전략
  • 경쟁 벤치마킹
    • 경쟁 벤치마킹 : 제품별
  • 시장 점유율 분석(2021년)
    • 세계의 혈장 분획/제품 시장 점유율 분석 : 기업별(2021년)
    • 세계의 면역글로불린 시장 점유율 분석 : 기업별(2021년)
    • 세계의 알부민 시장 점유율 분석 : 기업별(2021년)
    • 세계의 프로테아제 억제제 시장 점유율 분석 : 기업별(2021년)
    • 세계의 응고인자 시장 점유율 분석 : 기업별(2021년)

제10장 기업 개요

  • CSL Limited
  • Grifols, S.A.
  • Octapharma AG
  • Kedrion S.p.A.
  • Takeda Pharmaceutical Company Limited
  • China Biologic Products Holdings, Inc.
  • Bio Products Laboratory(BPL) Ltd
  • Intas Pharmaceuticals Ltd.
  • LFB Group
  • ADMA Biologics, Inc.
  • SK Plasma
  • GC Biopharma Corporation

제11장 부록

KSM 22.09.21

List of Tables

  • Table 1 Global Plasma Fractionation Market: Impact Analysis of Market Drivers (2022-2029)
  • Table 2 Number of Persons Aged 65 Years or Over, by Region (2019 Vs. 2030)
  • Table 3 U.S. and Europe: Plasma Collection Centers and Throughput, 2015-2019
  • Table 4 Recently Established Plasma Centers (2018-2022)
  • Table 5 Global Plasma Fractionation Market: Impact Analysis of Market Restraints (2022-2029)
  • Table 6 Plasmapheresis Parameters
  • Table 7 Global Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 8 Key Players offering Immunoglobulins
  • Table 9 Global Plasma-derived Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 10 Global Plasma-derived Immunoglobulins Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 11 Global Plasma-derived Immunoglobulins Market Volume, by Country/Region, 2020-2029 (100 Kg)
  • Table 12 Comparison of IVIg and SCIg
  • Table 13 Some Commercially Available IVIg Products and their Properties
  • Table 14 Global Plasma-derived Intravenous Immunoglobulins Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 15 Global Intravenous Immunoglobulins Volume, by Country/Region, 2020-2029 (100 Kg)
  • Table 16 Some Commercially Available SCIg Products and their Properties
  • Table 17 Global Plasma-derived Subcutaneous Immunoglobulins Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 18 Global Subcutaneous Immunoglobulins Market Volume, by Country/Region, 2020-2029 (100 Kg)
  • Table 19 Global Intramuscular Immunoglobulins Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 20 Global Intramuscular Immunoglobulins Market Volume, by Country/Region, 2020-2029 (100 Kg)
  • Table 21 Key Players offering Albumin
  • Table 22 Global Plasma-derived Albumin Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 23 Global Plasma-derived Albumin Market Volume, by Country/Region, 2020-2029(100 Kg)
  • Table 24 Key Players offering Protease Inhibitors
  • Table 25 Global Plasma-derived Protease Inhibitors Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 26 Global Plasma-derived Protease Inhibitors Market Volume, by Country/Region, 2020-2029 (Hundred Vials of 10 ml)
  • Table 27 Key Players offering Coagulation Factors
  • Table 28 Global Plasma-derived Coagulation Factors Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 29 Global Plasma-derived Coagulation Factors Market Volume, by Country/Region, 2020-2029 (Million Iu)
  • Table 30 Global Other Plasma-derived Products Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 31 Global Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 32 Key Vendors offering Plasma-derived Products for Neurological Applications
  • Table 33 Global Plasma Fractionation Market Size for Neurology, by Country/Region, 2020-2029 (USD Million)
  • Table 34 Key Players offering Products for Immunology Applications
  • Table 35 Global Plasma Fractionation Market Size for Immunology, by Country/Region, 2020-2029 (USD Million)
  • Table 36 Key Vendors offering Plasma-derived Products for Hematology
  • Table 37 Global Plasma Fractionation Market Size for Hematology, by Country/Region, 2020-2029 (USD Million)
  • Table 38 Key Vendors offering Plasma-derived Products for Critical Care
  • Table 39 Global Plasma Fractionation Market Size for Critical Care, by Country/Region, 2020-2029 (USD Million)
  • Table 40 Global Plasma Fractionation Market Size for Hematology-Oncology, by Country/Region, 2020-2029 (USD Million)
  • Table 41 Global Plasma Fractionation Market Size for Rheumatology and Orthopedics, by Country/Region, 2020-2029 (USD Million)
  • Table 42 Global Plasma Fractionation Market Size for Other Applications, by Country/Region, 2020-2029 (USD Million)
  • Table 43 Global Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 44 Global Plasma Fractionation Market Size for Hospitals & Clinics, by Country/Region, 2020-2029 (USD Million)
  • Table 45 Few Plasma Products Under Clinical Trials, 2016-2020
  • Table 46 Global Plasma Fractionation Market Size for Clinical Research Laboratories, by Country/Region, 2020-2029 (USD Million)
  • Table 47 Global Plasma Fractionation Market Size for Academic & Research Institutes, by Country/Region, 2020-2029 (USD Million)
  • Table 48 Global Plasma Fractionation Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 49 North America: Plasma Fractionation Market Size, by Country, 2020-2029 (USD Million)
  • Table 50 North America: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 51 North America: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 52 North America: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 53 North America: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 54 U.S.: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 55 U.S.: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 56 U.S.: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 57 U.S.: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 58 Canada: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 59 Canada: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 60 Canada: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 61 Canada: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 62 Europe: Plasma Fractionation Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 63 Europe: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 64 Europe: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 65 Europe: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 66 Europe: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 67 Germany: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 68 Germany: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 69 Germany: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 70 Germany: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 71 France: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 72 France: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 73 France: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 74 France: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 75 U.K.: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 76 U.K.: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 77 U.K.: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 78 U.K.: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 79 Italy: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 80 Italy: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 81 Italy: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 82 Italy: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 83 Spain: Hemoderivatives Production, 2013-2021
  • Table 84 Spain: Self-sufficiency for Plasma-derived Products
  • Table 85 Spain: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 86 Spain: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 87 Spain: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 88 Spain: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 89 Roe: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 90 Roe: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 91 Roe: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 92 Roe: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 93 Asia-Pacific: Plasma Fractionation Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 94 Asia-Pacific: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 95 Asia-Pacific: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 96 Asia-Pacific: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 97 Asia-Pacific: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 98 China: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 99 China: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 100 China: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 101 China: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 102 Japan: Domestic Production and Import of PDMP
  • Table 103 Japan: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 104 Japan: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 105 Japan: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 106 Japan: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 107 Australia: Blood and Blood Products Purchased by Product Category 2016-2017 to 2020-2021
  • Table 108 Australia: Current Products and Expected Transitioned Products by National Fractionation Agreement
  • Table 109 Australia: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 110 Australia: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 111 Australia: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 112 Australia: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 113 India: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 114 India: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 115 India: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 116 India: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 117 Indonesia: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 118 Indonesia: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 119 Indonesia: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 120 Indonesia: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 121 Vietnam: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 122 Vietnam: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 123 Vietnam: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 124 Vietnam: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 125 Thailand: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 126 Thailand: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 127 Thailand: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 128 Thailand: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 129 Malaysia: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 130 Malaysia: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 131 Malaysia: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 132 Malaysia: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 133 Roapac: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 134 Roapac: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 135 Roapac: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 136 Roapac: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 137 Latin America: Plasma Fractionation Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 138 Latin America: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 139 Latin America: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 140 Latin America: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 141 Latin America: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 142 Brazil: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 143 Brazil: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 144 Brazil: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 145 Brazil: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 146 Mexico: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 147 Mexico: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 148 Mexico: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 149 Mexico: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 150 Colombia: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 151 Colombia: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 152 Colombia: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 153 Colombia: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 154 Peru: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 155 Peru: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 156 Peru: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 157 Peru: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 158 Rest of Latin America: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 159 Rest of Latin America: Immunoglobulins Market Size, by Type, 2020-2029 (USD Million)
  • Table 160 Rest of Latin America: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 161 Rest of Latin America: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 162 Middle East & Africa: Plasma Fractionation Market Size, by Country, 2020-2029 (USD Million)
  • Table 163 Middle East & Africa: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 164 Middle East & Africa: Plasma Fractionation Market Size for Immunoglobulins, by Type, 2020-2029 (USD Million)
  • Table 165 Middle East & Africa: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 166 Middle East & Africa: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 167 South Africa: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 168 South Africa: Plasm Fractionation Market Size for Immunoglobulins, by Type, 2020-2029 (USD Million)
  • Table 169 South Africa: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 170 South Africa: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 171 Rest of Middle East & Africa: Population With Bleeding Disorder in 2020
  • Table 172 Rest of Middle East and Africa: Plasma Fractionation Market Size, by Product, 2020-2029 (USD Million)
  • Table 173 Rest of Middle East and Africa: Plasma Fractionation Market Size for Immunoglobulins, by Type, 2020-2029 USD Million)
  • Table 174 Rest of Middle East and Africa: Plasma Fractionation Market Size, by Application, 2020-2029 (USD Million)
  • Table 175 Rest of Middle East and Africa: Plasma Fractionation Market Size, by End User, 2020-2029 (USD Million)
  • Table 176 Recent Developments, by Company, 2020-2022

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Plasma Fractionation Market, by Product, 2022 Vs. 2029 (USD Million)
  • Figure 8 Global Plasma Fractionation Market, by Application, 2022 Vs. 2029 (USD Million)
  • Figure 9 Global Plasma Fractionation Market, by End User, 2022 Vs. 2029 (USD Million)
  • Figure 10 Global Plasma Fractionation Market, by Geography
  • Figure 11 Market Dynamics
  • Figure 12 Number of Genes Identified With in born Immunity Errors (2015-2019)
  • Figure 13 COVID-19 Associated Hospitalizations (As of 6th June 2020)
  • Figure 14 IVIg/SCIg Usage, by Country, 2005 Vs. 2014 Vs. 2018 (Kg/Million Population)
  • Figure 15 Comparison Between the Cost Structures of the Plasma in dustry and the Non-plasma Pharmaceutical Industry
  • Figure 16 Global Plasma Fractionation Market Size, by Product, 2022 Vs. 2029 (USD Million)
  • Figure 17 Global Sales of C1 Esterase Inhibitor (C1-INH) for Haematology Between 2010 and 2016 (USD Million)
  • Figure 18 Global Plasma Fractionation Market Size, by Application, 2022 Vs. 2029 (USD Million)
  • Figure 19 Percent Share of Polyvalent IGg in Plasma Proteins Market
  • Figure 20 Global Number of Orthopedic Surgeries, 2010-2020 (In Million)
  • Figure 21 Global Plasma Fractionation Market Size, by End User, 2022 Vs. 2029 (USD Million)
  • Figure 22 Global Plasma Fractionation Market Size, by Region, 2022 Vs. 2029 (USD Million)
  • Figure 23 North America: Plasma Fractionation Market Snapshot
  • Figure 24 U.S.: Number of Plasma Collection Centers, 2011-2020
  • Figure 25 Europe: Plasma Fractionation Market Snapshot
  • Figure 26 Italy: Plasma for Fractionation, 2007-2020
  • Figure 27 Asia-Pacific: Plasma Fractionation Market Snapshot
  • Figure 28 Latin America: Plasma Fractionation Market Snapshot
  • Figure 29 Rolatam: Number of Whole Blood Donations Collected From Voluntary Non-remunerated Donations, 2015-2019
  • Figure 30 Argentina: Number of People Suffering From Hemophilia (2018-2020)
  • Figure 31 Middle East & Africa: Plasma Fractionation Market Snapshot
  • Figure 32 South Africa: Number of Whole Blood Donations (2014-2019)
  • Figure 33 Algeria: Number of Voluntary Non-remunerated Whole Blood Donations
  • Figure 34 Key Growth Strategies Adopted by Leading Players, 2020-2022
  • Figure 35 Plasma Fractionation: Competitive Benchmarking Based on Product
  • Figure 36 CSL Limited: Financial Overview (2021)
  • Figure 37 Grifols, S.A.: Financial Overview (2021)
  • Figure 38 Octapharma AG: Financial Overview (2021)
  • Figure 39 Kedrion S.p.A.: Financial Overview (2021)
  • Figure 40 Takeda Pharmaceutical Company Limited: Financial Overview (2021)
  • Figure 41 China Biologic Products Holdings, Inc.: Financial Overview (2020)
  • Figure 42 Intas Pharmaceuticals Ltd: Financial Overview (2019)
  • Figure 43 ADMA Biologics, Inc.: Financial Overview (2021)
  • Figure 44 GC Biopharma Corporation: Financial Overview (2021)

The global plasma fractionation market is expected to grow at a CAGR of 7.1% from 2022 to 2029 to reach $46.88 billion by 2029.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. Manufacturing plasma-derived therapeutics requires regulated industrial processes to ensure optimal safety, quality, and recovery. Plasma derivatives are considered important therapeutic resources, owing to which the demand for plasma derivatives is rising. The plasma fractionation market is driven by the increasing prevalence of chronic diseases across all age groups, the growing use of immunoglobulins in various therapeutic areas, and the expansion of plasma collection centers. Further, the growing prevalence of blood and respiratory diseases is creating opportunities for market growth. However, factor such as government regulations in developing countries hampers the growth of this market to a certain extent.

Based on product, the plasma fractionation market is segmented into immunoglobulins, coagulation factors/concentrates, albumin, and protease inhibitors. In 2022, the immunoglobulins segment is expected to account for the largest share of the global plasma fractionation market. The growth of this segment is attributed to the large commercially available plasma-derived immunoglobulins compared to other products and the growth in the use of immunoglobulins, especially for primary immune deficiency.

Based on application, the market is segmented into immunology, hematology, neurology, critical care, hematology-oncology, rheumatology and orthopedics, and other applications. In 2022, the neurology segment is expected to dominate the plasma fractionation market. The growing prevalence of neurological disorders and the wide use of plasma-derived products for treating them is the major driving factor for this segment's growth.

Based on end user, the global plasma fractionation market is categorized into hospitals & clinics, clinical research laboratories, and academic institutes. In 2022, the hospitals & clinics segment is estimated to dominate the plasma fractionation market. The growing use of plasma-based products in multiple therapy areas, the growing number of hospitals, and the rising healthcare expenditure are some of the major factors driving the growth of this segment.

An in-depth analysis of the geographical scenario of the plasma fractionation market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is estimated to command the largest share of the global plasma fractionation market in 2022, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Some of the key players operating in the global plasma fractionation market are CSL Limited (Australia), Grifols, S.A. (Spain), Octopharma AG (Switzerland), Kedrion S.P.A. (Italy), Shire plc (U.K.), Biotest AG (Germany), China Biologic Products Holdings, Inc. (China), Bio Products Laboratory Ltd (U.K.), Japan Blood Products Organization (Japan), and Intas Pharmaceuticals Ltd. (India).

Key Questions Answered in the Report-

  • Which are the high-growth market segments in terms of product, application, end user, and geography?
  • What is the historical market size for the plasma fractionation market?
  • What are the market forecasts and estimates for the period 2022-2029?
  • What are the major drivers, restraints, opportunities, and challenges in the plasma fractionation market?
  • Who are the major players in the market, and what share of the market do they hold?
  • Who are the major players in various countries, and what market share do they hold?
  • How is the competitive landscape for the plasma fractionation market?
  • What are the recent developments in the plasma fractionation market?
  • What are the different strategies adopted by the major players in the market?
  • What are the key geographic trends, and which are the high-growth countries?
  • Who are the local emerging players in the gluten-free products market, and how do they compete with other players?

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Increasing Prevalence of Chronic Diseases Across All Age Groups
    • 4.2.2. Growing Use of Immunoglobulins in Various Therapeutic Areas
    • 4.2.3. Expansion of Plasma Collection Centers
  • 4.3. Restraints
    • 4.3.1. High Prices of Plasma Products
    • 4.3.2. Increasing Use of Recombinant Alternatives
  • 4.4. Opportunities
    • 4.4.1. Growing Prevalence of Blood & Respiratory Disorders
  • 4.5. Challenges
    • 4.5.1. Stringent Regulations in Developing Countries
  • 4.6. The Impact of COVID-19 on the Plasma Fractionation Market

5. Plasma Fractionation Market, by Product

  • 5.1. Introduction
  • 5.2. Immunoglobulins
    • 5.2.1. Intravenous Immunoglobulins (IVIg)
    • 5.2.2. Subcutaneous Immunoglobulins (SCIg)
    • 5.2.3. Intramuscular Immunoglobulins (IMIg)
  • 5.3. Albumin
  • 5.4. Protease Inhibitors
  • 5.5. Coagulation Factors
  • 5.6. Other Products

6. Plasma Fractionation Market, by Application

  • 6.1. Introduction
  • 6.2. Neurology
  • 6.3. Immunology
  • 6.4. Hematology
  • 6.5. Critical Care
  • 6.6. Hematology-Oncology
  • 6.7. Rheumatology and Orthopedics
  • 6.8. Other Applications

7. Plasma Fractionation Market, by End User

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Clinical Research Laboratories
  • 7.4. Academic & Research Institutes

8. Plasma Fractionation Market, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. Australia
    • 8.4.4. India
    • 8.4.5. Indonesia
    • 8.4.6. Vietnam
    • 8.4.7. Thailand
    • 8.4.8. Malaysia
    • 8.4.9. Rest of Asia Pacific (RoAPAC)
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Colombia
    • 8.5.4. Peru
    • 8.5.5. Rest of Latin America (RoLA)
  • 8.6. Middle East & Africa
    • 8.6.1. South Africa
    • 8.6.2. Rest of Middle East & Africa (RoMEA)

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
    • 9.3.1. Competitive Benchmarking, by Product
  • 9.4. Market Share Analysis (2021)
    • 9.4.1. Global Plasma Fractionation/Products Market Share Analysis, by Company (2021)
      • 9.4.1.1. CSL Limited
      • 9.4.1.2. Takeda Pharmaceutical Company Limited
      • 9.4.1.3. Grifols, S.A.
    • 9.4.2. Global Immunoglobulins Market Share Analysis, by Company, 2021
    • 9.4.3. Global Albumin Market Share Analysis, by Company, 2021
    • 9.4.4. Global Protease in hibitors Market Share Analysis, by Company, 2021
    • 9.4.5. Global Coagulation Factors Market Share Analysis, by Company, 2021

10. Company Profiles

  • 10.1. CSL Limited
  • 10.2. Grifols, S.A.
  • 10.3. Octapharma AG
  • 10.4. Kedrion S.p.A.
  • 10.5. Takeda Pharmaceutical Company Limited
  • 10.6. China Biologic Products Holdings, Inc.
  • 10.7. Bio Products Laboratory (BPL) Ltd
  • 10.8. Intas Pharmaceuticals Ltd.
  • 10.9. LFB Group
  • 10.10. ADMA Biologics, Inc.
  • 10.11. SK Plasma
  • 10.12. GC Biopharma Corporation.

11. Appendix

  • 11.1. Questionnaire
  • 11.2. Available Customization
Back to Top
전화 문의
F A Q